Friends and colleagues: In 2006, Roland Griffiths published a paper that reinstated, and transformed, the scientific study of psychedelic drugs. His study of single doses of psilocybin in healthy adults showed that these drugs are not only amenable to scientific investigation, but they have the potential to produce positive changes in our conceptions of consciousness and human experience. Since that first study, Roland has contributed to a burgeoning research field that has implications for psychiatry, psychology, religion, political and social norms, and for fundamental human experience. Now, as Dr. Griffiths is facing a life-threatening illness, he has established an endowment to ensure the continuation of what he views as the most consequential future direction of psychedelic research: Rigorous empirical investigation of psychedelic experiences resulting in enduring positive changes in well-being and prosocial attitudes and behavior. Notably, such a project is entirely dependent on philanthropic support. I encourage you to contribute to this worthy cause.
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383
Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky
Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.
No comments:
Post a Comment